CMPR

AI Memo

Cimpress

As of 2026-08-27/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-27 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

FY2027 guidance validation • 2026-10-28

Base target: $94 / p=50% prob

Biggest risk

FY2026 adjusted free cash flow fell to $122.4 million and operating cash flow declined to $283.7 million, while network expansion, software investment, tariffs, working capital, and leverage remain execution constraints. Phase 2 tariff refunds were not recognized because timing and acceptance remain uncertain [#10-K-2026-08-07].

Invalidation

Break below $74 or thesis failure.

What would change my mind?

FY2026 showed broad revenue growth, improving adjusted EBITDA, and strong VistaPrint contribution. The FY2027 outlook points to further EBITDA and free-cash-flow growth if acquisition contributions, manufacturing efficiencies, and cost actions are delivered [#10-K-2026-08-07][#SEC-8K-2026-07-29].

Research note

Recommendation

—

Confidence

medium

As of

2026-08-27

Base target

$94

p=50%

Bull target

$108

p=25%

Bear target

$74

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

FY2027 guidance validation
Tuck-in acquisition contribution and synergies
Manufacturing investment payoff

BearKey bullets

FY2026 adjusted free cash flow declined to $122.4 million despite revenue and EBITDA growth, making the FY2027 cash-flow recovery a key execution test [#10-K-2026-08-07].
North American production expansion added startup and other costs, while FY2026 capital expenditures and capitalized software investment remained substantial [#10-K-2026-08-07].
Recent insider Form 4 activity includes open-market sales and tax-withholding dispositions; the signal is ambiguous and should not be treated as evidence of operating deterioration [#SEC-FORM4-2026-08-18][#SEC-FORM4-2026-08-13].

WatchKey bullets

The supplied analyst target summary shows a $114.50 median, but analyst target count is unavailable, so it is not a reliable consensus measure.

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $94 (p=50%)

Target spread vs base: +15% / -21%

Scenario probabilities

Bull Target: $108 (p=25%)Base Target: $94 (p=50%)Bear Target: $74 (p=25%)

Commentary

News tone is constructive after the FY2026 release, supported by reported revenue and EBITDA growth and a stronger FY2027 framework. However, analyst revisions, options skew, short interest, employee sentiment, and sufficient social coverage are unavailable. The $87.25 anchor price does not establish an attributable post-earnings market reaction, so the evidence supports cautious monitoring rather than a high-conviction bullish stance.

As of 2026-08-27 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

FY2027 guidance validation
Tuck-in acquisition contribution and synergies
Manufacturing investment payoff

Scenarios

Bull Target (Scenario probability)

$108 / p=25% prob

Base Target (Scenario probability)

$94 / p=50% prob

Bear Target (Scenario probability)

$74 / p=25% prob

Analysis 2026-08-27 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.35

Social Sentiment (7d)

0.00

Short-term Catalysts

Next few weeks

FY2027 guidance validation
2026-10-28
FY2026 revenue increased 10% to $3.74 billion, organic constant-currency growth was 4%, and adjusted EBITDA rose to $458.5 million. Management's FY2027 framework calls for at least 7% reported growth, at least 3% organic constant-currency growth, adjusted EBITDA of at least $520 million, and approximately $200 million of adjusted free cash flow. The next earnings checkpoint will test execution against those targets [#SEC-8K-2026-07-29][#10-K-2026-08-07].
Prob 62% • Move 6% • Priced-in 65%

Long-term Catalysts

Months to a year

Tuck-in acquisition contribution and synergies
2027-06-30
Recent acquisitions contributed modestly in FY2026, while FY2027 expectations rely on a larger contribution from acquired revenue and initial synergies. Delivery would support the EBITDA and cash-flow targets; delays would weaken the forward thesis [#SEC-8K-2026-07-29].
Prob 58% • Move 8% • Priced-in 50%
Manufacturing investment payoff
2027-06-30
Cimpress invested heavily in its North American production network, with FY2026 gross profit absorbing additional expansion and startup costs and adjusted free cash flow declining to $122.4 million. Sustained cost efficiency and capacity benefits are important to realizing the FY2027 profitability and cash-generation outlook [#10-K-2026-08-07].
Prob 55% • Move 10% • Priced-in 45%

Risks

FY2026 adjusted free cash flow declined to $122.4 million despite revenue and EBITDA growth, making the FY2027 cash-flow recovery a key execution test [#10-K-2026-08-07].
North American production expansion added startup and other costs, while FY2026 capital expenditures and capitalized software investment remained substantial [#10-K-2026-08-07].
Recent insider Form 4 activity includes open-market sales and tax-withholding dispositions; the signal is ambiguous and should not be treated as evidence of operating deterioration [#SEC-FORM4-2026-08-18][#SEC-FORM4-2026-08-13].
The company carries substantial debt relative to cash, increasing sensitivity to interest expense, cash conversion, and execution setbacks [#10-K-2026-08-07].
U.S. tariff exposure remains volatile, including Section 301 tariffs and announced Canadian tariff measures; pricing and supply-chain mitigation may not fully offset future costs [#10-K-2026-08-07].

Peers

Symbol	Summary
PBI	Closest supplied comparator because of printing and mailing exposure, but detailed operating and valuation comparisons are unavailable.
HURN	Same-sector market-cap comparator, though consulting economics differ materially from Cimpress's mass-customization and manufacturing model.
INOD	Broad same-sector reference with a substantially different data-services business; limited comparability.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-27

Loading AI feed…

Symbol

Summary

PBI

Closest supplied comparator because of printing and mailing exposure, but detailed operating and valuation comparisons are unavailable.

HURN

Same-sector market-cap comparator, though consulting economics differ materially from Cimpress's mass-customization and manufacturing model.

INOD

Broad same-sector reference with a substantially different data-services business; limited comparability.